✦ LIBER ✦

Bright light therapy and melatonin in motor restless behaviour in dementia: a placebo-controlled study

✍ Scribed by P. M. Judith Haffmans; Rob C. Sival; Stefan A. P. Lucius; Quirine Cats; Lies van Gelder

Book ID: 101350100
Publisher: John Wiley and Sons
Year: 2001
Tongue: English
Weight: 82 KB
Volume: 16
Category: Article
ISSN: 0885-6230
DOI: 10.1002/1099-1166(200101)16:1<106::aid-gps288>3.0.co;2-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Bright light therapy for seasonal affect

Bright light therapy for seasonal affective disorder in Israel (latitude 32.6°N): a single case placebo-controlled study

✍ L. Moscovici 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 518 KB

Lavender oil as a treatment for agitated

Lavender oil as a treatment for agitated behaviour in severe dementia: a placebo controlled study

✍ Clive Holmes; Vivienne Hopkins; Christine Hensford; Vanessa MacLaughlin; David W 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 49 KB 👁 1 views

## Abstract ## Objective To determine whether aromatherapy with lavender oil is effective in the treatment of agitated behaviour in patients with severe dementia. ## Design A placebo controlled trial with blinded observer rater. ## Setting A long‐stay psychogeriatric ward. ## Patients Fiftee

A randomized, controlled trial of bright

A randomized, controlled trial of bright light therapy for agitated behaviors in dementia patients residing in long-term care

✍ Constantine G. Lyketsos; Lori Lindell Veiel; Alva Baker; Cynthia Steele 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB 👁 2 views

Background. Agitated behaviors are common in dementia patients residing in chronic care settings. Their occurrence may be associated with lack of adequate exposure to sunlight and with circadian rhythm disturbances. Objective. Prior research has suggested that bright light therapy (BLT) may reduce

Quetiapine treatment for behavioural and

Quetiapine treatment for behavioural and psychological symptoms of dementia in Alzheimer's disease patients: a 6-week, double-blind, placebo-controlled study

✍ D. Paleacu; Y. Barak; I. Mirecky; D. Mazeh 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB 👁 2 views

## Abstract ## Setting Treating elderly patients with Alzheimer's disease (AD) and behavioral and psychological symptoms of dementia (BPSD) is challenging due to the increased risk of iatrogenic movement disorders with old neuroleptics and the seemingly increasing risk of cardiovascular events wit